Houston Eccleston Holmes III, M.D.

NPI 1053354464ActiveIndividual· Internal Medicine, Hematology & Oncology· Dallas, TX

Internal Medicine, Hematology & Oncology (M.D.) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 1990). Their prescriptions cost Medicare Part D more than their services did: $5,340,930 for 753 claims, against $1,271,282 paid for services in 2024. Abbvie Inc. was the largest of 4 companies reporting payments in 2025, $346.93 in all, mostly food and beverage.

Overview

NPI	1053354464
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 14, 2006
Last updated in NPPES	Jun 14, 2011

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	H9998	TX
Internal Medicine, Medical Oncology	207RX0202X	H9998	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	506
Services billed	78,631 across 172 procedure codes
Paid by Medicare	$1,271,282

Part D prescriptions in 2024

Prescriptions (claims)	753 · 938 30-day fills
Patients	86
Total drug cost	$5,340,930
Generic share	50% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	1990
Medicare specialty	Hematology/Oncology
Secondary specialties	Internal Medicine, Medical Oncology
Telehealth	Offers telehealth